The F.T.C. and H.H.S. are examining the tactics of group purchasing organizations that generic industry executives say have led to scarce supplies of treatments like chemotherapy.
Israel’s technology sector, a key part of the economy, has been jolted by worker shortages and funding fears, which could drive a wider slowdown in 2024.